- Home
- OMEX vs IMMX Comparison
OMEX vs IMMX Comparison
Compare OMEX & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMEX
- IMMX
- Stock Information
- Founded
- OMEX 1986
- IMMX 2014
- Country
- OMEX United States
- IMMX United States
- Employees
- OMEX N/A
- IMMX N/A
- Industry
- OMEX Marine Transportation
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- OMEX Consumer Discretionary
- IMMX Health Care
- Exchange
- OMEX Nasdaq
- IMMX Nasdaq
- Market Cap
- OMEX 82.2M
- IMMX 82.6M
- IPO Year
- OMEX N/A
- IMMX 2021
- Fundamental
- Price
- OMEX $2.25
- IMMX $3.16
- Analyst Decision
- OMEX
- IMMX Strong Buy
- Analyst Count
- OMEX 0
- IMMX 1
- Target Price
- OMEX N/A
- IMMX $8.00
- AVG Volume (30 Days)
- OMEX 3.6M
- IMMX 774.5K
- Earning Date
- OMEX 11-19-2025
- IMMX 11-07-2025
- Dividend Yield
- OMEX N/A
- IMMX N/A
- EPS Growth
- OMEX N/A
- IMMX N/A
- EPS
- OMEX N/A
- IMMX N/A
- Revenue
- OMEX $620,048.00
- IMMX N/A
- Revenue This Year
- OMEX N/A
- IMMX N/A
- Revenue Next Year
- OMEX N/A
- IMMX N/A
- P/E Ratio
- OMEX $103.55
- IMMX N/A
- Revenue Growth
- OMEX N/A
- IMMX N/A
- 52 Week Low
- OMEX $0.27
- IMMX $1.34
- 52 Week High
- OMEX $4.43
- IMMX $4.05
- Technical
- Relative Strength Index (RSI)
- OMEX 47.04
- IMMX 51.33
- Support Level
- OMEX $1.73
- IMMX $2.85
- Resistance Level
- OMEX $2.06
- IMMX $4.05
- Average True Range (ATR)
- OMEX 0.26
- IMMX 0.39
- MACD
- OMEX -0.11
- IMMX -0.08
- Stochastic Oscillator
- OMEX 32.58
- IMMX 20.75
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.